IncobotulinumtoxinA Treatment in Upper-Limb Poststroke Spasticity in the Open-Label Extension Period of PURE: Efficacy in Passive Function, Caregiver Burden, and Quality of Life.
Christina MarciniakMichael C MuninAllison BrashearBruce S RubinAtul T PatelJaroslaw SlawekAngelika HanschmannReinhard HiersemenzelElie P ElovicPublished in: PM & R : the journal of injury, function, and rehabilitation (2020)
Repeated incobotulinumtoxinA treatments at 12-week intervals in participants with chronic poststroke upper-limb spasticity resulted in significant improvements in QoL, as well as significant reductions in upper-limb functional disability and caregiver burden.